Sertaconazole: In-Vitro antifungal activity against vaginal and other superficial yeast isolates

Journal of Chemotherapy

Volumn 13, Issue 5, 2001, Pages 555-562

  Carrillo Munoz A J ^a   Brio S ^a   Quindos G ^a   Palacin C ^a   Guglietta, A ^a   Espinel Ingroff, A ^a  

^a Dept Microbiologia ^*  (Spain)

Author keywords

Amphotericin B; Candida; Clotrimazole; Econazole; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Miconazole; NeoSensitabs; Sertaconazole; Tioconazole

Indexed keywords

AMPHOTERICIN B; AMPICILLIN; CLOTRIMAZOLE; ECONAZOLE; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; SERTACONAZOLE; TIOCONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; DRUG RESISTANCE; NONHUMAN; YEAST;

EID: 0034772658     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2001.13.5.555     Document Type: Article

References (32)

1. Epidemiología, diagnóstico y clinica de la vulvo-vaginitis candidásica
2. Management of genital candidiasis
3. Prevalence of skin disease in patients infected with human immunodeficiency virus in Bangkok, Thailand
4. Overview of medically important azole derivatives
5. Epidemiology and control of fungal infections
6. Molecular mycology: DNA probes and applications of PCR technology
7. Use of random amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit
8. The use of molecular techniques in the epidemiology and control of infectious diseases
9. Epidemiology of fungal infections: The promise of molecular typing
10. Application of biotyping and DNA typing of Candida albicans to the epidemiology of recurrent vulvo-vaginal candidiasis
11. The changing pattern of Candida infections: Different species and increased resistance
12. Fungal infections: A growing threat
13. Candidosis en unidades de cuidados intensivos
14. Torulopsis glabrata vaginitis
15. Inhibition of ergosterol synthesis by sertaconazole in Candida albicans
16. Direct membrane-damaging effect of sertaconazole on Candida albicans as a mechanism of its fungicidal activity
17. In vitro anti-fungal activity of sertaconazole, econazole and bifonazole against Candida spp.
18. In vitro antifungal activity of settaconazole
19. In vitro activity of sertaconazole
20. In vitro antifungal activity of sertaconazole, bifonazole, ketoconazole and miconazole against yeasts of the Candida genus
21. Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards Method M27-A and two other methods
22. Evaluación de un método de difusión en agar para el estudio de la sensibilidad in vitro a los antifúngicos frente a cepas de referencia
23. Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing
24. Comparación de dos métodos para el estudio de la sensibilidad in vitro a sertaconazol en aislamientos clinicos de levaduras
25. Multicenter survey of in vitro antifungal resistance in yeasts of medical importance isolated from Spanish patients
26. Tablet sensitivity testing of pathogenic fungi
27. Personal opinion: Can antifungal sensitivity tests predict clinical treatment outcomes?
28. Distribución de los aislamientos de levaduras de muestras clinicas recibidas en el laboratorio de Micología Médica, Universidad del País Vasco, desde 1989 hasta 1993
29. Antifungal activity of sertaconazole in vivo against clinical isolates of Candida spp.
30. Comparative study of antifungal activity of sertaconazole, terbinafine and bifonazole against clinical isolates of Candida spp., Cryptococcus neoformans and dermatophytes
31. Antifungal drug resistance in pathogenic fungi